Experienced in Gitelman Syndrome

Yanbing W. Li

58 Zhongshan 2nd Rd, 
Guangzhou, CN 
Experienced in Gitelman Syndrome
58 Zhongshan 2nd Rd, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Yanbing Li practices in Guangzhou, China. Li is rated as an Experienced expert by MediFind in the treatment of Gitelman Syndrome. Their top areas of expertise are Papillary Thyroid Cancer, Thyroid Cancer, Graves Disease, Type 2 Diabetes (T2D), and Thyroidectomy.

Their clinical research consists of co-authoring 213 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Gitelman Syndrome.

Locations

58 Zhongshan 2nd Rd, Guangzhou, 510080, China
Other Locations
No.58 Zhongshanerlu Road, Guangzhou, China
No. 58, Zhongshan Road 2, Guangzhou, 510080, China
58 # Zhongshan Road 2, Guangzhou, 510080, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Effects of Linagliptin and Metformin Monotherapy or Combined Sequential Treatment After Early Short-term Intensive Insulin Treatment on Long-term Blood Glucose Control and Function of β Cells in Patients With Type 2 Diabetes
Effects of Linagliptin and Metformin Monotherapy or Combined Sequential Treatment After Early Short-term Intensive Insulin Treatment on Long-term Blood Glucose Control and Function of β Cells in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: June 18, 2024
Intervention Type: Drug
Study Drugs: Continuous Subcutaneous Insulin Infusion followed by Lina+Metformin, Continuous Subcutaneous Insulin Infusion followed by Lina, Continuous Subcutaneous Insulin Infusion followed by Metformin, Continuous Subcutaneous Insulin Infusion
Study Phase: Phase 4

213 Total Publications

Global burden of blindness or visually impairment attributable to diabetic retinopathy in the adults aged 70 years and older, 1990-2021: Results from the global burden of disease study in 2021.
Global burden of blindness or visually impairment attributable to diabetic retinopathy in the adults aged 70 years and older, 1990-2021: Results from the global burden of disease study in 2021.
Journal: Diabetes research and clinical practice
Published: June 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Li's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile